The LUSZ COVID-19 Severity Index: A Prognostic and Predictive Score of Mortality for Hospitalized Patients With Covid-19
The LUSZ COVID-19 Severity Index: A Prognostic and Predictive Score of Mortality for Hospitalized Patients With Covid-19.
Sponsor: Hospital Saydet Zgharta University Medical Center
Listed as NCT05848427, this observational or N/A phase trial focuses on COVID-19 and remains actively recruiting participants. Sponsored by Hospital Saydet Zgharta University Medical Center, it has been updated 6 times since 2020, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Recruiting
-
Sep 2024 — Sep 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
May 2024 — Jul 2024 [monthly]
Recruiting
-
Aug 2023 — May 2024 [monthly]
Recruiting
▶ Show 1 earlier version
-
Jun 2023 — Aug 2023 [monthly]
Recruiting
First recorded
Mar 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Hospital Saydet Zgharta University Medical Center
- Lebanese University
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Tripoli, Lebanon
- • Zghartā, Lebanon